The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes
Authors:
- 1 April 2000
- journal article
- research article
- Published by SAGE Publications in Palliative Medicine
- Vol. 14 (3) , 205-208
Abstract
Varying concentrations of octreotide acetate (Sandostatin®) and diamorphine hydrochloride were prepared and stored in polypropylene syringes at 37°C in the dark. The solutions were analysed for octreotide acetate content using a validated HPLC method at regular intervals over a 48-h period. The results indicate that octreotide acetate remains stable in the presence of diamorphine hydrochloride at 37°C for 24 h. In addition, the solutions prepared maintained their clarity, with no signs of precipitation upon visual examination under normal light conditions.Keywords
This publication has 8 references indexed in Scilit:
- LC determination of octreotide acetate in compound formulations of Sandostatin® and diamorphine hydrochlorideJournal of Pharmaceutical and Biomedical Analysis, 1999
- Octreotide may prevent definitive intestinal obstructionJournal of Pain and Symptom Management, 1997
- Stability of octreotide acetate in polypropylene syringes at 5 and -20 ° CAmerican Journal of Health-System Pharmacy, 1995
- The role of octreotide in palliative careJournal of Pain and Symptom Management, 1994
- Octreotide in relieving gastrointestinal symptoms due to bowel obstructionPalliative Medicine, 1993
- Octreotide in the management of inoperable gastrointestinal obstruction in terminal cancer patientsJournal of Pain and Symptom Management, 1992
- Control of emesis in bowel obstruction in terminally ill patientsThe Lancet, 1992
- Diamorphine stability in aqueous solution for subcutaneous infusionJournal of Pharmacy and Pharmacology, 1989